Cargando…

Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine

We recently demonstrated by in vitro experiments that PLGA (poly D, L-lactide-co-glycolide) potentiates T helper 1 (Th1) immune responses induced by a peptide derived from the recombinant major outer membrane protein (rMOMP) of Chlamydia trachomatis, and may be a promising vaccine delivery system. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fairley, Stacie J, Singh, Shree R, Yilma, Abebayehu N, Waffo, Alain B, Subbarayan, Praseetha, Dixit, Saurabh, Taha, Murtada A, Cambridge, Chino D, Dennis, Vida A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682632/ https://www.ncbi.nlm.nih.gov/pubmed/23785233 http://dx.doi.org/10.2147/IJN.S44155

Ejemplares similares

Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles
por: Cambridge, Chino D, et al.
Publicado: (2013)

The Anti-Inflammatory Cytokine, Interleukin-10, Inhibits Inflammatory Mediators in Human Epithelial Cells and Mouse Macrophages Exposed to Live and UV-Inactivated Chlamydia trachomatis
por: Yilma, Abebayehu N., et al.
Publicado: (2012)

Flavonoid Naringenin: A Potential Immunomodulator for Chlamydia trachomatis Inflammation
por: Yilma, Abebayehu N., et al.
Publicado: (2013)

Anti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live Chlamydia trachomatis
por: Yilma, Abebayehu N, et al.
Publicado: (2013)

Generation of a novel affibody molecule targeting Chlamydia trachomatis MOMP
por: Li, Mingyang, et al.
Publicado: (2021)

Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a Chlamydia muridarum Genital Challenge and Re-Challenge
por: Sahu, Rajnish, et al.
Publicado: (2021)

Overexpression of the Bam Complex Improves the Production of Chlamydia trachomatis MOMP in the E. coli Outer Membrane
por: Huynh, Dung T., et al.
Publicado: (2022)

A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance
por: Badamchi-Zadeh, Alexander, et al.
Publicado: (2016)

MOMP in the absence of BH3-only proteins
por: García Sáez, Ana J., et al.
Publicado: (2016)

Minority MOMP: a toxic, slow demise
por: Xu, Yuan, et al.
Publicado: (2020)

Combining individual Chlamydia trachomatis IgG antibodies MOMP, TARP, CPAF, OMP2, and HSP60 for tubal factor infertility prediction
por: van Ess, Eleanne F., et al.
Publicado: (2019)

A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars
por: Olsen, Anja Weinreich, et al.
Publicado: (2021)

Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection
por: Jiang, Pengfei, et al.
Publicado: (2015)

Comparison of clinical performance of antigen based-enzyme immunoassay (EIA) and major outer membrane protein (MOMP)-PCR for detection of genital Chlamydia trachomatis infection
por: Nateghi Rostami, Mahmoud, et al.
Publicado: (2016)

Suppressors of Cytokine Signaling (SOCS)1 and SOCS3 Proteins Are Mediators of Interleukin-10 Modulation of Inflammatory Responses Induced by Chlamydia muridarum and Its Major Outer Membrane Protein (MOMP) in Mouse J774 Macrophages
por: Duncan, Skyla A., et al.
Publicado: (2020)

Necroptosis Interfaces with MOMP and the MPTP in Mediating Cell Death
por: Karch, Jason, et al.
Publicado: (2015)

Limited MOMP, ATM, and their roles in carcinogenesis and cancer treatment
por: Bao, Xuhui, et al.
Publicado: (2020)

Publisher Correction: A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars
por: Olsen, Anja Weinreich, et al.
Publicado: (2022)

MOMP, cell suicide as a BCL-2 family business
por: Kalkavan, Halime, et al.
Publicado: (2018)

Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes
Publicado: (1990)

Structural and Immunological Characterization of Novel Recombinant MOMP-Based Chlamydial Antigens
por: Madico, Guillermo, et al.
Publicado: (2017)

Advancements in prophylactic and therapeutic nanovaccines
por: Bhardwaj, Prateek, et al.
Publicado: (2020)

Pulmonary delivery of mucosal nanovaccines
por: Tang, Wei, et al.
Publicado: (2021)

Self-adjuvanting cancer nanovaccines
por: Liao, Zhiyun, et al.
Publicado: (2022)

Addressing Nanovaccine Strategies for Tilapia
por: Thompson, Kim D., et al.
Publicado: (2023)

Semisynthetic Pneumococcal Glycoconjugate Nanovaccine
por: Prasanna, Maruthi, et al.
Publicado: (2023)

Boolean network-based model of the Bcl-2 family mediated MOMP regulation
por: Tokar, Tomas, et al.
Publicado: (2013)

Peptide translocation across MOMP, the major outer membrane channel from Campylobacter jejuni
por: Dhanasekar, Naresh Niranjan, et al.
Publicado: (2017)

Fabrication of subunit nanovaccines by physical interaction
por: Chen, HaoLin, et al.
Publicado: (2022)

Applications of Nanovaccines for Disease Prevention in Cattle
por: Maina, Teresia W., et al.
Publicado: (2020)

Nanovaccines against Viral Infectious Diseases
por: Heng, Wen Tzuen, et al.
Publicado: (2022)

Nano toolbox in immune modulation and nanovaccines
por: Azharuddin, Mohammad, et al.
Publicado: (2022)

In Situ Cocktail Nanovaccine for Cancer Immunotherapy
por: Liu, Mohan, et al.
Publicado: (2023)

A Novel Transport Mechanism for MOMP in Chlamydophila pneumoniae and Its Putative Role in Immune-Therapy
por: Atanu, Francis O., et al.
Publicado: (2013)

Long-read sequencing for reliably calling the mompS allele in Legionella pneumophila sequence-based typing
por: Krøvel, Anne Vatland, et al.
Publicado: (2023)

Recombinant PBP2a/autolysin conjugate as PLGA-based nanovaccine induced humoral responses with opsonophagocytosis activity, and protection versus methicillin-resistant Staphylococcus aureus infection
por: Haghighat, Setareh, et al.
Publicado: (2022)

IgA and IgM protein primarily drive plasma corona‐induced adhesion reduction of PLGA nanoparticles in human blood flow
por: Sobczynski, Daniel J., et al.
Publicado: (2017)

A STING-Activating Nanovaccine for Cancer Immunotherapy
por: Luo, Min, et al.
Publicado: (2017)

A Magnetic Nanovaccine Enhances Cancer Immunotherapy
por: Guo, Yugang, et al.
Publicado: (2019)

Virus-Like Particles-Based Mucosal Nanovaccines
por: Rosales-Mendoza, Sergio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s32eg6vtnigcujfjlqihrv6ja8